<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Reprod Biol Endocrinol</journal-id><journal-id journal-id-type="iso-abbrev">Reprod. Biol. Endocrinol</journal-id><journal-title-group><journal-title>Reproductive Biology and Endocrinology : RB&#x00026;E</journal-title></journal-title-group><issn pub-type="epub">1477-7827</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23799974</article-id><article-id pub-id-type="pmc">3738149</article-id><article-id pub-id-type="publisher-id">1477-7827-11-55</article-id><article-id pub-id-type="doi">10.1186/1477-7827-11-55</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances cumulus cell expansion in bovine oocytes</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="A1"><name><surname>Peralta</surname><given-names>Oscar A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>operalta@uchile.cl</email></contrib><contrib contrib-type="author" equal-contrib="yes" id="A2"><name><surname>Bucher</surname><given-names>Danai</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>Danaibucher@uach.cl</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Fernandez</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>anitafernandezvet@yahoo.com</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Berland</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>mberland@uct.cl</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Strobel</surname><given-names>Pablo</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>pablostrobel@uach.cl</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Ramirez</surname><given-names>Alfredo</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>alfredoramirez@uach.cl</email></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="A7"><name><surname>Ratto</surname><given-names>Marcelo H</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>marceloratto@uach.cl</email></contrib><contrib contrib-type="author" corresp="yes" id="A8"><name><surname>Concha</surname><given-names>Ilona</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>conchagrabinger@uach.cl</email></contrib></contrib-group><aff id="I1"><label>1</label>Departamento de Fomento de la Producci&#x000f3;n Animal, Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Santiago, Chile</aff><aff id="I2"><label>2</label>Institutos de Ciencia Animal y Bioqu&#x000ed;mica y Microbiolog&#x000ed;a, Universidad Austral de Chile, Valdivia, Chile</aff><aff id="I3"><label>3</label>Facultad de Recursos Naturales, Universidad Cat&#x000f3;lica de Temuco, Temuco, Chile</aff><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>24</day><month>6</month><year>2013</year></pub-date><volume>11</volume><fpage>55</fpage><lpage>55</lpage><history><date date-type="received"><day>26</day><month>12</month><year>2012</year></date><date date-type="accepted"><day>17</day><month>6</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Peralta et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Peralta et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.rbej.com/content/11/1/55"/><abstract><sec><title>Background</title><p>The objectives of the study were to characterize the expression of the &#x003b1;- and &#x003b2;-subunits of granulocyte-macrophage colony stimulating factor (GM-CSF) receptor in bovine cumulus cells and oocytes and to determine the effect of exogenous GM-CSF on cumulus cells expansion, oocyte maturation, <italic>IGF-2</italic> transcript expression and subsequent competence for embryonic development.</p></sec><sec><title>Methods</title><p>Cumulus-oocyte complexes (COC) were obtained by aspirating follicles 3- to 8-mm in diameter with an 18&#x000a0;G needle connected to a vacuum pump at &#x02212;50&#x000a0;mmHg. Samples of cumulus cells and oocytes were used to detect GM- CSF receptor by immunofluorescence. A dose&#x02013;response experiment was performed to estimate the effect of GM-CSF on cumulus cell expansion and nuclear/cytoplasmic maturation. Also, the effect of GM-CSF on <italic>IGF-2</italic> expression was evaluated in oocytes and cumulus cells after <italic>in vitro</italic> maturation by Q-PCR. Finally, a batch of COC was randomly assigned to <italic>in vitro</italic> maturation media consisting of: 1) synthetic oviductal fluid (SOF, n&#x02009;=&#x02009;212); 2) synthetic oviductal fluid supplemented with 100&#x000a0;ng/ml of GM-CSF (SOF + GM-CSF, n&#x02009;=&#x02009;224) or 3) tissue culture medium (TCM 199, n&#x02009;=&#x02009;216) and then subsequently <italic>in vitro</italic> fertilized and cultured for 9&#x000a0;days.</p></sec><sec><title>Results</title><p>Immunoreactivity for both &#x003b1; and &#x003b2; GM-CSF receptors was localized in the cytoplasm of both cumulus cells and oocytes. Oocytes <italic>in vitro</italic> matured either with 10 or 100&#x000a0;ng/ml of GM-CSF presented a higher (P&#x02009;&#x0003c;&#x02009;0.05) cumulus cells expansion than that of the control group (0&#x000a0;ng/ml of GM-CSF). GM-CSF did not affect the proportion of oocytes in metaphase II, cortical granules dispersion and <italic>IGF-2</italic> expression. COC exposed to 100&#x000a0;ng/ml of GM-CSF during maturation did not display significant differences in terms of embryo cleavage rate (50.4% vs. 57.5%), blastocyst development at day 7 (31.9% vs. 28.7%) and at day 9 (17.4% vs. 17.9%) compared to untreated control (SOF alone, P&#x02009;=&#x02009;0.2).</p></sec><sec><title>Conclusions</title><p>GM-CSF enhanced cumulus cell expansion of <italic>in vitro</italic> matured bovine COC. However, GM-CSF did not increase oocyte nuclear or cytoplasmic maturation rates, <italic>IGF-2</italic> expression or subsequent embryonic development.</p></sec></abstract><kwd-group><kwd>GM-CSF</kwd><kwd>Oocyte maturation</kwd><kwd>Embryo development</kwd><kwd>GM-CSF receptors</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>The granulocyte-macrophage colony stimulating factor (GM-CSF) is a glycoprotein with several molecular-weight species ranging from 18 to 30&#x000a0;kDa [<xref ref-type="bibr" rid="B1">1</xref>]. Its receptor is comprised of two cytokine-specific &#x003b1;-subunits and two signal transducing &#x003b2;-subunits [<xref ref-type="bibr" rid="B2">2</xref>]. Upon binding, the GM-CSF-receptor complex is capable of stimulating proliferation, maturation and viability of hematopoietic and non-hematopoietic cells [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. The interaction of GM-CSF with its receptor stimulates multiple signal transduction pathways, including Jak/STAT pathway, Ras/Raf/mitogen-activated protein kinase pathway, phosphatidylinositol 3-kinase (PI 3-kinase)/protein kinase B (PKB) pathway, and protein kinase C (PKC) pathway [<xref ref-type="bibr" rid="B5">5</xref>]. GM-CSF promote glucose uptake through PI 3-kinase/PKB pathway via translocation of glucose transporter 1 (GLUT 1) [<xref ref-type="bibr" rid="B4">4</xref>]. GM-CSF induction of the PKB/Akt pathway results in direct cell survival activity and inactivation of proapoptotic factors BAD, caspase 9 and forkhead [<xref ref-type="bibr" rid="B6">6</xref>]. Additionally, Akt promotes cell survival indirectly by regulating a number of processes involved in glucose metabolism [<xref ref-type="bibr" rid="B6">6</xref>].</p><p>Both GM-CSF and its receptor have been highly characterized in the hematopoietic cell line, as well as in other cell types including fibroblasts, oligodendrocytes, trophoblast, endothelial and neoplastic [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B10">10</xref>]. In reproductive tissues, GM-CSF has been detected in testis, placenta, uterus, oviduct and ovary [<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B15">15</xref>]. GM-CSF is expressed in utero by luminal and glandular epithelial cells and is subsequently secreted into the uterine lumen where activates neutrophils and macrophages during estrous cycle and early pregnancy [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B16">16</xref>]. The GM-CSF receptor has been detected from the fertilized oocyte through blastocysts stage in both mice and humans [<xref ref-type="bibr" rid="B17">17</xref>]. The selective expression of GM-CSF in theca, granulosa and lutheal cells coincides with peak follicular development, ovulation and luteinization [<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>]. In mice, cumulus-oocytes complexes (COC) express mRNA for the &#x003b1;-subunit of GM-CSF receptor, which has been reported to facilitates glucose uptake and thereby promote viability and proliferation in certain cell lineages [<xref ref-type="bibr" rid="B21">21</xref>]. Changes in estrogen and progesterone concentrations regulate the production of GM-CSF which suggests a potential regulatory function during the estrus cycle [<xref ref-type="bibr" rid="B14">14</xref>]. Thus, the expression of GM-CSF in the mouse ovary and uterus and its steroidogenic regulation suggest an autocrine/paracrine role in the ovarian physiology and embryonic development.</p><p>Oogenesis relies on the highly coordinated interaction between the oocyte and surrounding cells; the oocyte regulates follicular cell proliferation and differentiation and follicular cells control oocyte meiotic arrest [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>]. Interaction of cumulus with the oocyte provides local production of glycosaminoglycans, steroid hormones, nutrients and other factors that support oocyte maturation [<xref ref-type="bibr" rid="B24">24</xref>-<xref ref-type="bibr" rid="B26">26</xref>]. Thereafter, presence of cumulus cells during IVF enhances fertilization and embryo development rates by facilitating sperm selection, capacitation, acrosome reaction and penetration [<xref ref-type="bibr" rid="B24">24</xref>]. Most of the energy required for these processes is supplied by glycolysis. However, glycolysis is limited during oogenesis due to reduced glucose transport and hexokinase activity in the oocyte [<xref ref-type="bibr" rid="B27">27</xref>]. <italic>In vitro</italic> studies have shown that cumulus cells are able to uptake and metabolize glucose allowing transport of glycolytic products such as pyruvate and lactate through gap junctions into the oocyte [<xref ref-type="bibr" rid="B28">28</xref>]. Pyruvate and lactate are easily oxidized by the oocyte becoming the main energy source during maturation [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B29">29</xref>]. Glucose might also be metabolized through the pentose-phosphate pathway (PPP) playing an important role in nucleotide biosynthesis and glutathione reduction during meiotic maturation and pronuclear formation [<xref ref-type="bibr" rid="B29">29</xref>]. Moreover, hyaluronic acid formation during cumulus expansion requires conversion of glucose into extracellular matrix components including glutamine [<xref ref-type="bibr" rid="B30">30</xref>]. Thus, the effect of GM-CSF on cumulus cells may potentially result in higher glucose uptake and cell proliferation or survival enhancing cumulus expansion. Alternatively, GM-CSF produced by macrophages within the ovarian stroma and theca cell layer may influence steroidogenesis and differentiation of thecal and follicular cells [<xref ref-type="bibr" rid="B20">20</xref>]. Taking these data together, we hypothesized that GM-CSF activity in the bovine COC may enhance oocyte maturation, cumulus expansion and subsequent embryonic development. To estimate the potential effect of GM-CSF at the transcription level, the expression of <italic>IGF-2</italic> may be quantified in bovine cumulus and oocytes after IVM. <italic>IGF-2</italic> is an imprinted gene in various mammal species and encodes an essential growth factor that plays a crucial role in tissue differentiation, fetal growth, and placental development [<xref ref-type="bibr" rid="B31">31</xref>]. In addition, <italic>IGF-2</italic> is believed to stimulate granulosa cells to produce estradiol, enhancing oocyte maturation [<xref ref-type="bibr" rid="B32">32</xref>].</p><p>The first objective of the current study was to characterize the expression of the &#x003b1;- and &#x003b2;-subunits of the GM- CSF receptor in bovine cumulus cells and oocytes. The second objective was to estimate the effect of exogenous GM-CSF on nuclear and cytoplasmic oocyte maturation, cumulus expansion, <italic>IGF-2</italic> transcript expression and subsequent competence for embryonic development.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Collection of oocytes and cumulus cells</title><p>All cell culture reagents were obtained from Sigma, unless otherwise specified. Bovine ovaries were obtained from a local abattoir and transported to the laboratory immersed in 0.85% saline supplemented with 100&#x000a0;mg/ml of Streptomycin and 80&#x000a0;mg/mL Sodium Penicillin G at a temperature of 35&#x02013;38&#x000b0;C within 3&#x000a0;h of collection. Cumulus-oocyte complexes (COC) were obtained by aspirating follicles 3- to 8-mm in diameter with an 18&#x000a0;G needle connected to a vacuum pump at &#x02212;50&#x000a0;mmHg. The follicular fluid was deposited in 60-ml tubes containing PBS-Dulbecco (8&#x000a0;mg/ml NaCl, 0.2&#x000a0;mg/ml KCl, 1.15&#x000a0;mg/ml KH<sub>2</sub>PO<sub>4</sub>, 0.10&#x000a0;mg/ml MgCl<sub>2</sub>&#x02009;+&#x02009;6H<sub>2</sub>O, 0.10&#x000a0;mg/ml CaCl<sub>2</sub>, 0.036&#x000a0;mg/ml sodium pyruvate, 1.00&#x000a0;mg/ml glucose) supplemented with BSA (3&#x000a0;mg/ml) and gentamicin (50&#x000a0;&#x003bc;g/ml).</p></sec><sec><title>Immunofluorescence for GM-CSF detection in bovine oocytes and granulosa cells</title><p>Granulosa cells and oocytes were washed in 0.1&#x000a0;M PBS (pH&#x000a0;7.4, Gibco BRL) and fixed in a mixture of Histochoice and ethanol (4:1). Cumulus cells were obtained by vortexing COC for 5&#x000a0;minutes in PBS-0.1% BSA. Cells were then permeabilized and blocked in a solution of 0.1&#x000a0;M PBS with 1% BSA, 5% skim milk and 0.3% Triton X-100 for 60&#x000a0;min at room temperature. Cells were incubated in blocking solution (without Triton X-100) containing polyclonal antibodies (1:200; N-20 and C-18 for the GM-CSF alpha and beta subunit receptors respectively, Santa Cruz Biotechnology, California, USA) raised against the carboxyl and amino terminals of the &#x003b1;- and &#x003b2;-GM-CSF receptor subunits, respectively. After three washes with PBS, cells were incubated with anti-rabbit, anti-goat and anti-mouse IgGs (1:300 in blocking buffer) conjugated to Alexa Fluor 488 and 594&#x000a0;nm (Molecular Probes, California, USA), respectively. Cells were again washed three times in PBS and mounted under coverslips in a solution containing 4&#x02019;, 6-diamidino-2-phenylindole (DAKO Laboratories, Denmark). Samples were examined under confocal microscope and photos were obtained using photomicroscopy (Olympus Fluoview 1000, Tokyo, Japan).</p></sec><sec><title>In vitro maturation of cumulus oocyte complexes</title><p>After follicular aspiration, COC were classified into five groups based on the morphology of their surrounding cumulus cells [<xref ref-type="bibr" rid="B33">33</xref>]. Group A: with many layers of compact cumulus cells; Group B: with partially removed cumulus cells; Group C: denuded oocytes; Group D: degeneration of oocyte cytoplasm; Group E: expanded cumulus cells. Only COC classified as Group A and B were used in this study. Cumulus-oocyte complexes were then washed twice in PBS-Dulbecco (Gibco BRL) and twice in maturation media according to each treatment. Maturation media consisted of SOF (107.7&#x000a0;mM NaCL, 7.16&#x000a0;mM KCl, 1.19&#x000a0;mM KH<sub>2</sub>PO<sub>4</sub>, 1.5&#x000a0;mM D-glucose, 5&#x000a0;mM Taurine, 1.71&#x000a0;mM CaCL<sub>2</sub>, 0.49&#x000a0;mM MgCl<sub>2</sub>, 3.3&#x000a0;mM Sodium lactate and 25.07&#x000a0;mM NaHCO<sub>3</sub>) at pH&#x000a0;7.4 supplemented with aminoacids BME 50&#x000d7; (20&#x000a0;&#x003bc;l/ml), MEM 100x (10&#x000a0;&#x003bc;l/ml), BSA FV (8&#x000a0;mg/ml) and gentamicin (50&#x000a0;&#x003bc;g/ml). Cumulus oocyte complexes were randomly assigned to SOF medium supplemented with Recombinant human GM-CSF (hGM-CSF 215-GM-010 (R&#x00026;D System, Inc., Minneapolis, USA) at concentrations of 1 (n&#x02009;=&#x02009;71), 10 (n&#x02009;=&#x02009;59) and 100&#x000a0;ng/ml (n&#x02009;= 89) [0.07, 0.7 and 7 nM, respectively]. Two additional groups were incorporated in the experimental design: SOF alone (n&#x02009;=&#x02009;75) and a positive control maturation media consisted of tissue culture medium (n&#x02009;=&#x02009;95) [TCM; 15&#x000a0;mg/ml TCM 199, 2.2&#x000a0;mg/ml NaHCO<sub>3</sub> at pH&#x000a0;7.4] supplemented with 10% FBS (Hyclone, Utah, USA), 0.2&#x000a0;&#x003bc;M Pyruvate, 5&#x000a0;&#x003bc;g/ml LH (Lutropin, Bioniche, Belleville, Canada), 40&#x000a0;mg/ml FSH (Folltropin, Bioniche, Bellevile, Canada) and 50&#x000a0;&#x003bc;g/ml gentamicin.</p><p>Groups of 10&#x02013;15 COC were allocated for <italic>in vitro</italic> maturation (IVM) in 50-&#x003bc;l droplets of treatment media in Petri dishes under mineral oil for 22&#x000a0;h in humidified atmosphere consisting in 5% CO<sub>2</sub> at 38.5&#x000b0;C.</p></sec><sec><title>Assessment of cumulus expansion and oocyte nuclear maturation</title><p>After 22&#x000a0;h of IVM, oocytes were collected and evaluated according to the cumulus expansion and then nuclear maturation. Cumulus expansion was determined using three different methods: 1) higher and a lower diameter for each COC were measured using a micrometric rule previously calibrated using a 0.1&#x000a0;mm objective (Nikon); 2) oocytes were microphotographed and higher and lower diameters were measured using a Fluoview software (FV 1000-ASW 1.4.3; Olympus, Corporation, Japan); and 3) a subjective scale was used [<xref ref-type="bibr" rid="B34">34</xref>] to estimate the degree of cumulus expansion. The degree of cumulus expansion was measured as follows: 0, no expansion; +1, separation of only the outermost layer of cumulus cells; + 2, further expansion involving the outer half of the cumulus oophorus; +3, further expansion up to, but not including, the corona radiate; +4, complete expansion, including the innermost corona radiate cells. A cumulus expansion index (CEI) [<xref ref-type="bibr" rid="B35">35</xref>] was calculated according to the subjective scale previously described using the following formula: CEI = (+1xn) + (+2xn) + (+3xn) + (+4xn) / N. Where CEI is the index for a given treatment, n is the total number of COC observed for each scale value in each treatment and N is the total number of COC in each treatment.</p><p>After cumulus expansion evaluation, cumulus cells were removed mechanically by vortex in PBS-0.1% BSA and washed twice in the same solution. Oocytes were placed between glass and cover slides with silicone and fixed with a mixture of acetic acid and ethanol (1:3) overnight at room temperature. Oocytes were then stained using 1% aceto-orcein for 1&#x000a0;h and destained using a mixture of acetic acid, glycerol and distilled water (1:1:3). Stained oocytes were examined under a phase contrast microscope for intact nucleus with germinal vesicle (GV), germinal vesicle breakdown (GVBD) or metaphase II (MII)-arrested.</p></sec><sec><title>Determination of cumulus cell number and viability</title><p>Cumulus oocyte complexes (n&#x02009;=&#x02009;52-60/per group) were randomly assigned to the following <italic>in vitro maturation</italic> media: SOF alone, SOF supplemented with GM-CSF at a concentration of 1, 10 or 100&#x000a0;ng/ml of GM-CSF or TCM 199 as described above. Groups of 10&#x02013;15 COC were allocated for <italic>in vitro</italic> maturation (IVM) in 50-&#x003bc;l droplets of treatment media in Petri dishes under mineral oil for 22&#x000a0;h in humidified atmosphere consisting of 5% CO<sub>2</sub> at 38.5&#x000b0;C. An additional sample of COC (n&#x02009;=&#x02009;40-45/per group) was <italic>in vitro</italic> matured in SOF medium alone or supplemented with 10 and 100&#x000a0;&#x003bc;M of LY294002 a PI 3-kinase inhibitor or DMSO (DMSO was used as a diluent control). Cumulus cells were removed mechanically by vortex in PBS-0.1% BSA at 22&#x000a0;h. A 50&#x000a0;&#x003bc;l aliquot of cell suspension was mixed with 5&#x000a0;&#x003bc;l of Trypan Blue for cell viability using a Neubauer chamber.</p></sec><sec><title>Assessment of oocyte cytoplasmic maturation</title><p>Cumulus oocyte complexes were randomly assigned to the following <italic>in vitro maturation</italic> media: 1- SOF without GM-CSF supplementation (n&#x02009;=&#x02009;123), 2- SOF supplemented with 100&#x000a0;ng/ml of GM-CSF or 3- TCM 199 as described above (n&#x02009;=&#x02009;159).</p><p>Immunohistochemical staining for cortical granules was also performed for evaluation of oocyte cytoplasm maturation. The type of cortical granules (type I, aggregates; type II, aggregates with some dispersion and type III, dispersion of granules) was evaluated as previously described [<xref ref-type="bibr" rid="B36">36</xref>]. Briefly, the zona pellucida was removed using 0.5% (w/v) pronase and oocytes were fixed in 4% (w/v) paraformaldehyde for 30&#x000a0;minutes. Oocytes were permeabilized with 0.25% Triton X-100 and washed with blocking solution (PBS containing 2% (w/v) BSA, 2% non-fat milk and 0.15&#x000a0;M glycine). Staining was performed using 10&#x000a0;mg/ml lens culinaris conjugated to fluorescein isothiocyanate (FITC, Sigma L9267, St Louis, USA).</p><p>Oocytes were examined and evaluated under epifluorescence inverted microscope (Nikon Corporation, Tokyo, Japan).</p></sec><sec><title>Quantitative PCR</title><p>Relative expression of <italic>IGF-2</italic> gene transcript in bovine cumulus cells and oocytes were determined in COC (n&#x02009;=&#x02009;30 per group) in <italic>vitro</italic> matured in TCM, SOF alone or supplemented with 100&#x000a0;ng/ml of GM-CSF. Total RNA was extracted from lysed cells using the RNAeasy extraction mini kit (Qiagen Inc., Valencia, CA, USA). All subsequent RNA purification steps were carried out according to the manufacturer&#x02019;s instructions. cDNA was synthesized using the oligo-dT method (Promega Corp., Madison, WI, USA) with 1&#x000a0;&#x003bc;g of total RNA as a template in a reaction volume of 20&#x000a0;&#x003bc;l. Sequences of forward and reverse bovine <italic>IGF-2</italic> were: ATCCAGCCGCATAAACCG and GGACGGTACAGGGATTTCAG. A reaction mixture containing a volume of 50&#x000a0;&#x003bc;l was prepared (5&#x000a0;&#x003bc;l 10&#x000d7; PCR buffer, 2&#x000a0;&#x003bc;l dNTPs mix 10&#x000a0;mM, 2.5&#x000a0;&#x003bc;l forward and reverse primers 10&#x000a0;&#x003bc;M, molecular biology grade water and 0.5&#x000a0;&#x003bc;l Taq DNA polymerase). All the reagents were acquired from Promega. The reaction was heated on a Stratagene Thermo Cycler (GRI Systems, UK) to 95&#x000b0;C for 7&#x000a0;min, followed by 35&#x000a0;cycles of 94&#x000b0;C for 30&#x000a0;s, 55&#x000b0;C for 30&#x000a0;s, 72&#x000b0;C for 1&#x000a0;min, and a final extension step of 72&#x000b0;C for 10&#x000a0;min. As a normalization control for RNA loading, parallel reactions in the same multiwell plate were performed using <italic>GAPDH</italic> as a target. Quantification of gene amplification was made following quantitative PCR by determining the threshold cycle (C<sub>T</sub>) number for SYBR fluorescence within the geometric region of the semilog plot generated during PCR. Within this region of the amplification curve, each difference of one cycle is equivalent to a doubling of the amplified product of the PCR. The relative quantification of the target gene expression across treatment was evaluated using the comparative &#x02206;&#x02206;C<sub>T</sub> method. The C<sub>T</sub> value was determined by subtracting the <italic>GAPDH</italic> C<sub>T</sub> value from the target C<sub>T</sub> value of the sample. Calculation of &#x02206;&#x02206; C<sub>T</sub> involved using target gene expression on immature control (sample with the highest CT value or lowest target expression) as an arbitrary constant to subtract from all other C<sub>T</sub> sample values. Relative target mRNA expression was calculated as fold changes in relation to immature control sample and expressed as 2<sup>-&#x02206;&#x02206;CT</sup> value.</p></sec><sec><title>In vitro fertilization and embryo development</title><p>A sample of COC was randomly assigned to <italic>in vitro</italic> maturation media consisting of: 1) SOF alone (SOF, n&#x02009;=&#x02009;212); 2) SOF supplemented with 100&#x000a0;ng/ml of GM-CSF (SOF + GM-CSF, n&#x02009;=&#x02009;224) or 3) Tissue Culture Medium (TCM 199, n&#x02009;=&#x02009;216) and then subsequently <italic>in vitro</italic> fertilized and cultured for 9&#x000a0;days.</p><p>Embryos were produced using standard protocols for <italic>in vitro</italic> maturation, fertilization and culture [<xref ref-type="bibr" rid="B36">36</xref>-<xref ref-type="bibr" rid="B39">39</xref>]. Frozen-thawed semen from bulls of proven fertility (ABS, American Breeders Service, DeForest, WI, USA) was used for in vitro fertilization (IVF). The content of one 0.25-ml straw of frozen Holstein Friesian semen was thawed in water at 35&#x02013;37&#x000b0;C. Thawed sperm were washed in a discontinuous gradient of 45/90% Percoll using centrifugation at 700&#x000a0;g for 20&#x000a0;min. The pellet was resuspended with washing medium TALP (Tyrode&#x02019;s albumin lactate pyruvate) containing 6&#x000a0;mg/mL BSA (Fraction V), 1.0&#x000a0;mM Sodium Pyruvate and 5&#x000a0;&#x003bc;g/mL of gentamicin and centrifuged once again at 250&#x000a0;g for 5&#x000a0;minutes. After being centrifuged, the spermatozoa in pellets were counted and the volume adjusted to give a concentration of approximately 1.5-2 &#x000d7; 10<sup>6</sup> sperm/ml of heparin-containing (1&#x000a0;&#x003bc;g/ml) TALP-IVF medium (TALP without glucose supplemented with 4&#x000a0;mg/ml BSA, 100&#x000a0;IU/ml penicillin and streptomycin, 0.1&#x000a0;mM pyruvate, and 2&#x000a0;&#x003bc;g/ml heparin). The sperm suspension was pippeted into 35&#x000a0;mm-petri dishes in 50&#x000a0;&#x003bc;l microdrops and covered with mineral oil. Thereafter, 10&#x02013;12 matured COC per drop were added and incubated in 5% CO2 and 5% O2 in humidified air at 38.5&#x000b0;C. After 18&#x02013;20&#x000a0;h, the presumptive zygotes were vortexed in PBS-0.1% BSA medium to remove the cumulus cells. Denuded zygotes were cultures in 30&#x000a0;&#x003bc;l of bicarbonate-buffered SOF medium for 7&#x000a0;days in a humid chamber under an atmosphere containing 5% CO<sub>2</sub>, 5% O<sub>2</sub> and 90%&#x000a0;N<sub>2</sub>.</p></sec><sec><title>Embryo development and total cell number of blastocysts</title><p>Early cleavage was evaluated on Day 2 after <italic>in vitro</italic> fertilization (Day 0&#x02009;=&#x02009;in vitro fertilization) and blastocyst formation were recorded on Days 7 and 9 of <italic>in vitro</italic> culture. Blastocysts from days 9 of <italic>in vitro</italic> culture (n&#x02009;=&#x02009;30/per group) were used for cell number determination. Embryos were placed on a slide with dye bisbenzimide (Bis, Hoechst 33342, 10&#x000a0;&#x003bc;g/ml) for 5&#x000a0;min at 39&#x000b0;C. Hoechst dye was removed, and cover lips were mounted with wax and then firmly pushed onto the slide to spread the embryo. Staining nuclei was visualized with an epifluorescence microscope (Olympus, Tokyo, Japan).</p></sec><sec><title>Statistical analysis</title><p>Single point measurements such as the difference among treatments for cumulus expansion, nuclear and cytoplasmic maturation, and <italic>IGF-2</italic> mRNA levels were estimated using one-way analysis of variance (ANOVA). Tukey&#x02019;s multiple comparison was used as a post-hoc test when a significant difference was detected. Data from cumulus diameter was normalized to a logarithmic scale in order to accomplish homocedasticity. CEI and number of cells values were compared among treatments using non-parametric Kruskal-Wallis and multicomparison tests. Data from cellular viability were arcsin-transformed and analyzed using one-way ANOVA and Tukey&#x02019;s test. All statistical analyses were performed using the Statistica 7.0 (StatSoft, Inc., Oklahoma, USA) software package.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Expression of the GM-CSF receptor in bovine cumulus cells and oocytes</title><p>Immunofluorescence analyses were performed to detect expression of &#x003b1; and &#x003b2; receptors of GM-CSF in whole-mounted bovine cumulus cells (Figure&#x000a0;<xref ref-type="fig" rid="F1">1</xref>A-F) and oocytes (Figure&#x000a0;<xref ref-type="fig" rid="F2">2</xref>A-F). Specimen (cells or oocytes) incubated without the first (primary) antibody showed no signal (Figures&#x000a0;<xref ref-type="fig" rid="F1">1</xref>A,B; <xref ref-type="fig" rid="F2">2</xref>A,B).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Expression of GM-CSF &#x003b1; and &#x003b2; receptors in bovine cumulus cells.</bold> Confocal microscopy analysis was performed using anti-GM-CSFr&#x003b1; and anti-GM-CSFr&#x003b2; antibodies. <bold>A</bold>, <bold>B:</bold> Specimen incubated without the first (primary) antibody showed no signal. <bold>C</bold>, <bold>D:</bold> GM-CSFr&#x003b1; subunit (green). <bold>E</bold>, <bold>F:</bold> GM-CSFr&#x003b2; subunit (green). Cell nuclei were stained using propidum iodide (red). Scale bar&#x02009;=&#x02009;10&#x000a0;&#x003bc;m.</p></caption><graphic xlink:href="1477-7827-11-55-1"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Expression of GM-CSF &#x003b1; and &#x003b2; receptors in bovine COC.</bold> Confocal microscopy analysis was performed using anti-GM-CSFr&#x003b1; and anti-GM-CSFr&#x003b2; antibodies. <bold>(A</bold>, <bold>B)</bold> Specimen incubated without the first (primary) antibody showed no signal. <bold>C</bold>, <bold>D:</bold> GM-CSFr&#x003b1; subunit (green). <bold>E</bold>, <bold>F:</bold> GM-CSFr&#x003b2; subunit (green). Oocyte nuclei were stained using propidum iodide (red). Scale bar&#x02009;=&#x02009;100&#x000a0;&#x003bc;m.</p></caption><graphic xlink:href="1477-7827-11-55-2"/></fig></sec><sec><title>Effect of GM-CSF on the bovine oocyte in vitro maturation</title><p>A dose&#x02013;response experiment was performed to estimate the effect of GM-CSF on nuclear maturation. The maturation state was evaluated using aceto-orcein staining. Data showed that the proportion of oocytes undergoing metaphase II after treatment with 1, 10 or 100&#x000a0;ng/ml of GM-CSF was not significantly different compared to the untreated controls (59.2, 54.2, 59.6 and 54.7%, respectively; Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>). However, a higher proportion of metaphase II oocytes were found in the TCM treatment (83.2%).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p><bold>Dose&#x02013;response effect of the GM-CSF on nuclear maturation of bovine oocytes matured </bold><bold>
<italic>in vitro </italic>
</bold></p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left" valign="bottom"><bold>Treatment</bold><hr/></th><th align="left" valign="bottom"><bold>COC</bold><hr/></th><th align="left" valign="bottom"><bold>GV</bold><hr/></th><th align="left" valign="bottom"><bold>GVBD</bold><hr/></th><th align="left" valign="bottom"><bold>MI</bold><hr/></th><th align="left" valign="bottom"><bold>MII</bold><hr/></th></tr><tr><th align="left">&#x000a0;</th><th align="left"><bold>(n)</bold></th><th align="left"><bold>(%)</bold></th><th align="left"><bold>(%)</bold></th><th align="left"><bold>(%)</bold></th><th align="left"><bold>(%)</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom"><italic>SOF</italic><hr/></td><td align="left" valign="bottom">75<hr/></td><td align="left" valign="bottom">11/78 (14.6)<hr/></td><td align="left" valign="bottom">9/75 (12.0)<hr/></td><td align="left" valign="bottom">14/75 (18.7)<hr/></td><td align="left" valign="bottom">41/75 (54.7)<hr/></td></tr><tr><td align="left" valign="bottom"><italic>SOF + GM-CSF (1&#x000a0;ng/ml)</italic><hr/></td><td align="left" valign="bottom">71<hr/></td><td align="left" valign="bottom">11/71 (15.5)<hr/></td><td align="left" valign="bottom">5/71 (7.0)<hr/></td><td align="left" valign="bottom">13/71 (18.3)<hr/></td><td align="left" valign="bottom">42/71 (59.2)<hr/></td></tr><tr><td align="left" valign="bottom"><italic>SOF + GM-CSF (10&#x000a0;ng/ml)</italic><hr/></td><td align="left" valign="bottom">59<hr/></td><td align="left" valign="bottom">8/59 (13.6)<hr/></td><td align="left" valign="bottom">4/59 (6.8)<hr/></td><td align="left" valign="bottom">15/59 (25.4)<hr/></td><td align="left" valign="bottom">32/59 (54.2)<hr/></td></tr><tr><td align="left" valign="bottom"><italic>SOF + GM-CSF (100&#x000a0;ng/ml)</italic><hr/></td><td align="left" valign="bottom">89<hr/></td><td align="left" valign="bottom">14/89 (15.7)<hr/></td><td align="left" valign="bottom">4/89 (4.5)<hr/></td><td align="left" valign="bottom">18/89 (20.2)<hr/></td><td align="left" valign="bottom">53/89 (59.6)<hr/></td></tr><tr><td align="left"><italic>TCM</italic></td><td align="left">95</td><td align="left">1/95 (1.0)</td><td align="left">4/95 (4.2)</td><td align="left">11/95 (11.6)</td><td align="left">79/95 (83.2*)</td></tr></tbody></table><table-wrap-foot><p><italic>GV</italic> Germinal Vesicle, <italic>GVBD</italic> Geminal Vesicle Break-Down, <italic>MI</italic> metaphase I.</p><p><italic>MII</italic> metaphase II. (*) Indicate significant differences between treatments (P&#x02009;&#x0003c;&#x02009;0.05).</p><p>(There were 3 replicates for this experiment).</p></table-wrap-foot></table-wrap><p>Further analyses were performed to estimate cytoplasmic maturation by cytoplasmic granule visualization using a fluorescence-labeled lectin. Treatment with 100&#x000a0;ng/ml of GM-CSF resulted in no significant differences in terms of percentage of type III oocytes compared to untreated or TCM controls (51.1, 55.3 and 53.5%; Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p><bold>Effect of the GM-CSF factor on the type of cortical granules dispersion (cytoplasmic maturation) of </bold><bold>
<italic>in vitro </italic>
</bold><bold>matured bovine oocytes</bold></p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left" valign="bottom"><bold>Treatment</bold><hr/></th><th align="left" valign="bottom"><bold>COC</bold><hr/></th><th align="left" valign="bottom"><bold>Type I</bold><hr/></th><th align="left" valign="bottom"><bold>Type II</bold><hr/></th><th align="left" valign="bottom"><bold>Type III</bold><hr/></th></tr><tr><th align="left">&#x000a0;</th><th align="left"><bold>(n)</bold></th><th align="left"><bold>(%)</bold></th><th align="left"><bold>(%)</bold></th><th align="left"><bold>(%)</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom"><italic>SOF</italic><hr/></td><td align="left" valign="bottom">123<hr/></td><td align="left" valign="bottom">37/123 (30.1)<sup>a</sup><hr/></td><td align="left" valign="bottom">18/123 (14.6)<sup>b</sup><hr/></td><td align="left" valign="bottom">68/123 (55.3)<sup>c</sup><hr/></td></tr><tr><td align="left" valign="bottom"><italic>SOF + GM-CSF (100&#x000a0;ng/ml)</italic><hr/></td><td align="left" valign="bottom">133<hr/></td><td align="left" valign="bottom">42/133 (31.6)<sup>a</sup><hr/></td><td align="left" valign="bottom">23/133 (17.3)<sup>b</sup><hr/></td><td align="left" valign="bottom">68/133 (51.1)<sup>c</sup><hr/></td></tr><tr><td align="left"><italic>TCM*</italic></td><td align="left">159</td><td align="left">28/159 (17.6)<sup>a</sup></td><td align="left">46/159 (2.9)<sup>b</sup></td><td align="left">85/159 (53.5)<sup>c</sup></td></tr></tbody></table><table-wrap-foot><p><sup>a,b,c</sup> Different superscripts within columns indicate significant difference (P&#x02009;&#x0003c;&#x02009;0.05).</p><p>(There were 4 replicates for this experiment).</p></table-wrap-foot></table-wrap></sec><sec><title>Effect of GM-CSF on the bovine cumulus expansion and cell viability</title><p>Cumulus expansion as an indirect indicator of oocyte maturation was estimated by calculating major diameters of cumulus and CEI before and after IVM. An increase (P&#x02009;&#x0003c;&#x02009;0.001) in cumulus diameter was observed in COC treated with 10 and 100&#x000a0;ng/ml of GM-CSF (329&#x02009;&#x000b1;&#x02009;68 and 400&#x02009;&#x000b1;&#x02009;88&#x000a0;&#x003bc;m) compared with control COC (0&#x000a0;ng/ml, 295&#x02009;&#x000b1;&#x02009;57&#x000a0;&#x003bc;m; Figure&#x000a0;<xref ref-type="fig" rid="F3">3</xref>). Similarly, determination of CEI showed that both 10 and 100&#x000a0;ng/ml treatments induced higher (P&#x02009;&#x0003c;&#x02009;0.05) cumulus expansion (0.85 and 1.22) after maturation compared to the untreated control (0.25; Figure&#x000a0;<xref ref-type="fig" rid="F4">4</xref>A). To test whether GM-CSF has a direct effect on cumulus expansion, an inhibitor of the PI 3-kinase was added to the media. Addition of 10 or 100&#x000a0;&#x003bc;M of PI 3-kinase inhibitor to GM-CSF treated COC resulted in lower (P&#x02009;&#x0003c;&#x02009;0.05) cumulus expansion (0.4 and 0.26) compared to COC matured only with GM-CSF (1.05; Figure&#x000a0;<xref ref-type="fig" rid="F4">4</xref>B). The DMSO control showed no effect on cumulus expansion. After cumulus evaluation, cumulus cells were separated individually, stained using Trypan Blue and counted using a Neubauer chamber. Percentage of live cumulus cells decreased after <italic>in vitro</italic> maturation from 63.4&#x02009;&#x000b1;&#x02009;14.3% to 45.2&#x02009;&#x000b1;&#x02009;5.3% (Figure&#x000a0;<xref ref-type="fig" rid="F4">4</xref>C). However, treatment with 10 and 100&#x000a0;ng/ml of GM-CSF resulted in higher (P&#x02009;&#x0003c;&#x02009;0.001) percentage of live cells (57.2&#x02009;&#x000b1;&#x02009;5.9 and 65.1 &#x000b1;6.6%, respectively) compared to untreated cells (45.2&#x02009;&#x000b1;&#x02009;5.3%). Treatment with 100&#x000a0;&#x003bc;M of PI 3-kinase inhibitor and GM-CSF resulted in lower (P&#x02009;&#x0003c;&#x02009;0.001) percentage of live cells (41.1&#x02009;&#x000b1;&#x02009;10.3%) compared to cells treated with GM-CSF alone (56.5&#x02009;&#x000b1;&#x02009;13%) and cells treated with GM-CSF and 10&#x000a0;&#x003bc;M of PI3-kinase inhibitor (Figure&#x000a0;<xref ref-type="fig" rid="F4">4</xref>D). To determine the potential effect of GM-CSF on cumulus cell proliferation, the total number of cells (live and dead) from all treatment groups were determined as described above (Figure&#x000a0;<xref ref-type="fig" rid="F4">4</xref>E). Total cell number increased (P&#x02009;&#x0003c;&#x02009;0.001) after the addition of 100&#x000a0;ng/ml of GM-CSF (147.4%) compared to untreated control (100%). Treatment with 10 and 100&#x000a0;ng/ml of GM-CSF resulted in more live cells (63.3%, P&#x02009;&#x0003c;&#x02009;0.01 and 92.3%, P&#x02009;&#x0003c;&#x02009;0.001, respectively) compared to the untreated control (44.5%). The addition of 100&#x000a0;&#x003bc;M of PI 3-kinase inhibitor in presence of GM-CSF resulted in lower number of total cells (94.1%, P&#x02009;&#x0003c;&#x02009;0.01) and live cells (42.3%, P&#x02009;&#x0003c;&#x02009;0.01) compared to cells treated with GM-CSF alone (140.2&#x02009;&#x000b1;&#x02009;13% and 79.3%, Figure&#x000a0;<xref ref-type="fig" rid="F4">4</xref>F).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Effect of GM-CSF on diameters of cumulus in </bold><bold><italic>in vitro </italic></bold><bold>matured COC. </bold><bold>(A)</bold> COC (n&#x02009;=&#x02009;52-56/per group) were <italic>in vitro</italic> matured in SOF medium alone or supplemented with 1, 10 and 100 nM of GM-CSF. <bold>(B)</bold> Higher (P&#x02009;&#x0003c;&#x02009;0.001) diameters were detected in COC matured in presence of 10 and 100&#x000a0;ng/ml of GM-CSF compared to untreated COC. Time 0 corresponds with the immature state of the oocytes. Parameters from oocytes in the immature state and matured in TCM were used as positive control and not included in the statistical analysis. (*) Indicate significant (P&#x02009;&#x0003c;&#x02009;0.001) differences between treatments of 0, 1 and 100&#x000a0;ng/ml of GM-CSF.</p></caption><graphic xlink:href="1477-7827-11-55-3"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>Effect of GM-CSF on cumulus cell in </bold><bold><italic>in vitro </italic></bold><bold>matured COC.</bold> (Left Graphs) COC were matured in SOF medium alone or supplemented with 1, 10 and 100 nM of GM-CSF. Parameters from cumulus cells derived from oocytes in the immature state and matured in TCM were used as positive control and not included in the statistical analysis. (Right Graphs) COC were matured in SOF medium supplemented with GM-CSF, LY294002 (10 or 100&#x000a0;&#x003bc;M) or DMSO. <bold>(A</bold>, <bold>B)</bold> Cumulus cell expansion was evaluated subjectively using the cumulus expansion index (CEI). <bold>(C</bold>, <bold>D)</bold> Cell viability was evaluated using Trypan Blue staining. <bold>(E</bold>, <bold>F)</bold> Cell number was determined using hemocytometer. (&#x02212;&#x02212;&#x02212;) Corresponds with the lower limit for cumulus expansion (CEI&#x02009;&#x02265;&#x02009;0.5). (*) Indicate significant differences between treatments of 0, 1 and 100&#x000a0;ng/ml of GM-CSF. *** P&#x02009;&#x0003c;&#x02009;0.001, ** P&#x02009;&#x0003c;&#x02009;0.01 and *P&#x02009;&#x0003c;&#x02009;0.05. (#) Indicate significant differences compared with control ### P&#x0003c; 0.001, ## P&#x0003c; 0.01, # P &#x0003c; 0.05.</p></caption><graphic xlink:href="1477-7827-11-55-4"/></fig><p>Furthermore, we evaluated the effect of GM-CSF during <italic>in vitro</italic> maturation on the mRNA <italic>IGF-2</italic> levels by Q-PCR. Relative <italic>IGF-2</italic> mRNA expression increased (P&#x02009;&#x0003c;&#x02009;0.05) in cumulus cells and oocytes after in vitro maturation compared to the immature state. GM-CSF induced no significant effect over <italic>IGF-2</italic> expression neither in cumulus cells or oocytes (P&#x02009;&#x0003e;&#x02009;0.05; Figure&#x000a0;<xref ref-type="fig" rid="F5">5</xref>). However, <italic>IGF-2</italic> expression was up-regulated (P&#x02009;&#x0003c;&#x02009;0.05) in cumulus cells and oocytes after maturation in TCM (2.81 and 2.64 fold compared to the immature control).</p><fig id="F5" position="float"><label>Figure 5</label><caption><p><bold>Relative expression of </bold><bold><italic>IGF-2 </italic></bold><bold>gene transcript.</bold> (mean &#x000b1; SEM) in bovine cumulus cells (black bars) and oocytes (grey bars) in COC (n&#x02009;=&#x02009;30/per group) <italic>in vitro</italic> matured in TCM, SOF alone or supplemented with 100&#x000a0;ng/ml of GM-CSF. (*) Indicate significant differences compared with immature control (IC). Different superscripts (a,b,c) indicate significant (P&#x02009;&#x0003c;&#x02009;0.05) difference.</p></caption><graphic xlink:href="1477-7827-11-55-5"/></fig></sec><sec><title>Determination of the GM-CSF effect during oocyte maturation on subsequent embryo development</title><p>In order to evaluate the effect of GM-CSF <italic>in vitro</italic> maturation on subsequent embryonic development we utilized COC matured in TCM, SOF and SOF&#x02009;+&#x02009;100&#x000a0;ng/ml of GM-CSF for in vitro fertilization. Results showed that COC exposed to 100&#x000a0;ng/ml of GM-CSF during maturation did not display significant differences in terms of embryo cleavage rate (50.4% vs. 57.5%), blastocyst development at day 7 (31.9% vs. 28.7%) and at day 9 (17.4% vs. 17.9%) or embryonic nuclei count (98 vs. 96) compared to untreated controls (P&#x02009;&#x0003e;&#x02009;0.05; Table&#x000a0;<xref ref-type="table" rid="T3">3</xref>). However, oocytes matured in TCM showed higher (P&#x02009;&#x0003c;&#x02009;0.05) cleavage and blastocyst development rates compared to oocytes matured in SOF and in SOF supplemented with 100&#x000a0;ng/ml of GM-CSF.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p><bold>Fertilization and embryo development rates from bovine oocytes </bold><bold>
<italic>in vitro </italic>
</bold><bold>matured in TCM, SOF or SOF supplemented with 100&#x000a0;ng/ml of GM-CSF</bold></p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left"><bold>Treatment</bold></th><th align="left"><bold>Oocytes (n)</bold></th><th align="left"><bold>Cleavage (%)</bold></th><th align="left"><bold>Blastocysts day 7 (%)</bold></th><th align="left"><bold>Blastocysts/ cleavage day 9 (%)</bold></th><th align="left"><bold>Blastocyst/ oocytes day 9 (%)</bold></th><th align="left"><bold>Embryonic nuclei (n)</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom"><italic>TCM</italic><hr/></td><td align="left" valign="bottom">216<hr/></td><td align="left" valign="bottom">146 (67.6)<sup>a</sup><hr/></td><td align="left" valign="bottom">55 (37.7)<sup>a</sup><hr/></td><td align="left" valign="bottom">60 (41.1)<sup>a</sup><hr/></td><td align="left" valign="bottom">27.8<sup>a</sup><hr/></td><td align="left" valign="bottom">108.2&#x02009;&#x000b1;&#x02009;7.7<hr/></td></tr><tr><td align="left" valign="bottom"><italic>SOF</italic><hr/></td><td align="left" valign="bottom">212<hr/></td><td align="left" valign="bottom">122 (57.5)<sup>b</sup><hr/></td><td align="left" valign="bottom">35 (28.7)<sup>b</sup><hr/></td><td align="left" valign="bottom">38 (31.1)<sup>b</sup><hr/></td><td align="left" valign="bottom">17.9<sup>b</sup><hr/></td><td align="left" valign="bottom">98&#x02009;&#x000b1;&#x02009;12.6<hr/></td></tr><tr><td align="left"><italic>SOF + GM-CSF (100&#x000a0;ng/ml)</italic></td><td align="left">224</td><td align="left">113 (50.4)<sup>b</sup></td><td align="left">36 (31.9)<sup>b</sup></td><td align="left">39 (34.5)<sup>b</sup></td><td align="left">17.4<sup>b</sup></td><td align="left">96&#x02009;&#x000b1;&#x02009;13.1</td></tr></tbody></table><table-wrap-foot><p><sup>a,b</sup> Different superscripts within columns indicate significant differences (P&#x02009;&#x0003c;&#x02009;0.05). (There were 4 replicates for this experiment).</p></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Immunofluorescence analyses demonstrated a wide distribution of &#x003b1;- and &#x003b2;- subunits of the GM-CSF receptor in bovine oocytes and cumulus cells. Immunolabeling associated to both &#x003b1; and &#x003b2; receptors appeared to be located in the cytoplasm of cumulus cells. Oocytes collected from antral follicles were stripped from cumulus cells and processed for immunofluorescence analyses. Confocal microscopy showed a pattern of immunoreactivity for the &#x003b1; receptor in the cytoplasm in proximity to the plasmatic membrane. In contrast, the &#x003b2; subunit was homogeneously distributed in the cytoplasm. A previous report indicated the expression of the &#x003b1;-subunit but not the &#x003b2;- subunit in mouse COC by RT-PCR [<xref ref-type="bibr" rid="B20">20</xref>]. However, sections of mice and human ovarian tissue analyzed by in situ hybridization showed the transcript of both &#x003b1;- and &#x003b2; subunits as well as the GM-CSF ligand in the oocyte, theca, granulosa and luteal cells [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. Moreover, RT-PCR analysis detected the expression of both subunits in human granulosa-lutein cell culture preparations [<xref ref-type="bibr" rid="B11">11</xref>]. Giving the abundant expression of GM-CSF receptor in bovine oocytes and granulosa cells, it is possible that this cytokine may play a significant role in the local regulation of the ovarian physiology. Evidence indicating a functional role of GM-CSF in reproduction has been provided by studies using GM-CSF knockout (GM-CSF &#x02212;/&#x02212;) mice. These animals exhibited longer estrous cycles, delayed blastocyst development, smaller litter size and higher rate of fetal death [<xref ref-type="bibr" rid="B40">40</xref>]. However, the biological role of GM-CSF has recently been associated to glucose transport in several non-hematopoietic cells including the spermatozoa [<xref ref-type="bibr" rid="B41">41</xref>]. GM-CSF increased glucose uptake via functional facilitative hexose transporters GLUT improving the freezing/thawing resistance and subsequent linear motility [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B41">41</xref>]. These finding, together with observations that GM-CSF and both subunits of the GM-CSF receptor are expressed in bovine oocytes and granulosa cells, suggest that GM-CSF may activate cumulus expansion and oocyte maturation, enhancing subsequent embryonic development. Our data demonstrates that supplementation of GM-CSF during <italic>in vitro</italic> maturation has no effect on the proportion of oocytes undergoing nuclear or cytoplasmic maturation. However, supplementation of GM-CSF induced higher cumulus expansion in <italic>in vitro</italic> matured bovine COC. Inhibition of the phosphatidylinositol 3 (PI3)-kinase prevented the GM-CSF effect, suggesting that the 3PI-kinase pathway is associated with glucose uptake, mediated by the activity of GM-CSF.</p><p>Addition of 100&#x000a0;ng/ml to cumulus cell culture resulted in higher percentage of total cells (45.4% higher) compared to untreated controls. The proportion of nonviable cells remained similar to controls indicating that a higher proportion of live cells accounted for the total cells. These data suggest that GM-CSF induced proliferation instead of survival of cumulus cells. The proliferative effect of GM-CSF was blocked after addition Ly294002 indicating that PI3- kinase activity mediated the GM-CSF effect. The intracellular signaling that intermediates proliferative and survival effects of GM-CSF have been previously characterized [<xref ref-type="bibr" rid="B42">42</xref>]. The proliferative effect is mediated by activation of major tyrosine phosphorylation-dependent signaling pathways including Jak/signal transducer and activator of transcription, Ras/mitogen-activated protein kinase, and PI3-kinase [<xref ref-type="bibr" rid="B43">43</xref>].</p><p>To estimate the effect of GM-CSF at the transcription level we quantified the expression of <italic>IGF-2</italic> in bovine cumulus and oocytes after IVM. Our results showed that <italic>IGF-2</italic> expression in cumulus cells and oocytes was not affected by GM-CSF treatment during in vitro maturation. However, we found that <italic>IGF-2</italic> was up-regulated in cumulus cells and oocytes after maturation. Moreover, <italic>IGF-2</italic> expression increased in oocytes and cumulus cells after maturation in TCM compared to maturation in SOF or supplementation with GM-CSF. Previous studies have suggested that <italic>IGF-2</italic> play an autocrine and paracrine role associated to survival activity in embryos cultured under suboptimal conditions [<xref ref-type="bibr" rid="B44">44</xref>]. These data suggest that <italic>IGF-2</italic> expression may be modulated by culture conditions but not by supplementation of GM-CSF.</p><p>We further tested the effect of GM-CSF on cumulus expansion and the potential effect on oocyte competence by evaluating the embryonic development of COC matured with GM-CSF. Cumulus expansion has been associated with several oocyte functions including ovulation, cleavage and embryonic development [<xref ref-type="bibr" rid="B24">24</xref>-<xref ref-type="bibr" rid="B26">26</xref>]. Cumulus cells also play an important role during fertilization by stimulating sperm selection and motility [<xref ref-type="bibr" rid="B25">25</xref>]. Using an <italic>in vitro</italic> system, oocytes treated with and without GM-CSF were fertilized with frozen/thawed semen and cultured in SOF for 9&#x000a0;days. We found no differences among treatments on cleavage rate, blastocyst development and embryonic nuclei count. These results indicate that the effect of GM-CSF on cumulus expansion during maturation was not sufficient to improve the subsequent embryonic development. Previous studies have showed that addition of GM-CSF to culture media improved development rates in bovine [<xref ref-type="bibr" rid="B45">45</xref>] and human [<xref ref-type="bibr" rid="B46">46</xref>] embryos. Moreover, exposure of bovine [<xref ref-type="bibr" rid="B47">47</xref>] and human [<xref ref-type="bibr" rid="B48">48</xref>] embryos to GM-CSF during development increased the percentage that developed to term.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>In conclusion, both &#x003b1;- and &#x003b2;-subunits of the GM- CSF receptor are expressed in bovine cumulus cells and oocytes. Despite, GM-CSF enhanced cumulus cell expansion of <italic>in vitro</italic> matured bovine COC, the oocyte nuclear and cytoplasmic maturation, <italic>IGF-2</italic> mRNA levels or subsequent competence for embryonic development was not affected by the GM-CSF treatment. Our data suggest that GM-CSF may play a role in cumulus cell expansion <italic>in vitro</italic> and increasing cell proliferation.</p></sec><sec><title>Competing interest</title><p>The authors declare that they have not competing interest.</p></sec><sec><title>Authors&#x02019; contributions</title><p>DB participated in designing the study, acquisition, analysis and interpretation of data, and in writing and revising the manuscript. OAP, AF, MOB participated in the acquisition and interpretation of the data. PS and AR participated in analysis and interpretation of data and critical revision of the manuscript. As Principal Investigators, MR and IC participated in the intellectual and experimental design of the study, the acquisition, analysis and interpretation of data, as well as writing and revising the manuscript. All authors read and approved the final manuscript.</p></sec></body><back><sec><title>Acknowledgements</title><p>We thank Drs. Maite A Castro and Constanza Angulo for their expert guidance and assistance in confocal microscopy. This study was supported by: Direcci&#x000f3;n de Investigaci&#x000f3;n, Universidad Austral de Chile grant S-2009-26 and Universidad Cat&#x000f3;lica de Temuco, grant 2007 DGI-CDA-04, FONDECYT 1110508.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Hill</surname><given-names>AD</given-names></name><name><surname>Naama</surname><given-names>HA</given-names></name><name><surname>Calvano</surname><given-names>SE</given-names></name><name><surname>Daly</surname><given-names>JM</given-names></name><article-title>The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications</article-title><source>J Leukoc Biol</source><year>1995</year><volume>6</volume><fpage>634</fpage><lpage>642</lpage><pub-id pub-id-type="pmid">7499960</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Bagley</surname><given-names>CJ</given-names></name><name><surname>Woodcock</surname><given-names>JM</given-names></name><name><surname>Stomski</surname><given-names>FC</given-names></name><name><surname>Lopez</surname><given-names>AF</given-names></name><article-title>The structural and functional basis of cytokine receptor activation: lessons from the common beta subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 receptors</article-title><source>Blood</source><year>1997</year><volume>89</volume><fpage>1471</fpage><lpage>1482</lpage><pub-id pub-id-type="pmid">9057626</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Ruef</surname><given-names>C</given-names></name><name><surname>Coleman</surname><given-names>DL</given-names></name><article-title>Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness</article-title><source>Rev Infect Dis</source><year>1990</year><volume>1</volume><fpage>41</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">2405468</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Zambrano</surname><given-names>A</given-names></name><name><surname>Jara</surname><given-names>E</given-names></name><name><surname>Murgas</surname><given-names>P</given-names></name><name><surname>Jara</surname><given-names>C</given-names></name><name><surname>Castro</surname><given-names>MA</given-names></name><name><surname>Angulo</surname><given-names>C</given-names></name><name><surname>Concha</surname><given-names>II</given-names></name><article-title>Cytokine stimulation promotes increased glucose uptake via translocation at the plasma membrane of GLUT1 in HEK293 cells</article-title><source>J Cell Biochem</source><year>2010</year><volume>110</volume><fpage>1471</fpage><lpage>1480</lpage><pub-id pub-id-type="doi">10.1002/jcb.22711</pub-id><pub-id pub-id-type="pmid">20506349</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>de Groot</surname><given-names>RP</given-names></name><name><surname>Coffer</surname><given-names>PJ</given-names></name><name><surname>Koenderman</surname><given-names>L</given-names></name><article-title>Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family</article-title><source>Cell Signal</source><year>1998</year><volume>10</volume><fpage>619</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.1016/S0898-6568(98)00023-0</pub-id><pub-id pub-id-type="pmid">9794243</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Datta</surname><given-names>SR</given-names></name><name><surname>Brunet</surname><given-names>A</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name><article-title>Cellular survival: a play in three akts</article-title><source>Genes Dev</source><year>1999</year><volume>13</volume><fpage>2905</fpage><lpage>2927</lpage><pub-id pub-id-type="doi">10.1101/gad.13.22.2905</pub-id><pub-id pub-id-type="pmid">10579998</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Metcalf</surname><given-names>D</given-names></name><name><surname>Nicola</surname><given-names>N</given-names></name><name><surname>Gearing</surname><given-names>D</given-names></name><name><surname>Gough</surname><given-names>N</given-names></name><article-title>Low-affinity placenta-derived receptors for human granulocyte macrophage colony-stimulating factor can deliver a proliferative signal to murine hemopoietic cells</article-title><source>Proc Natl Acad Sci USA</source><year>1990</year><volume>87</volume><fpage>4670</fpage><lpage>4674</lpage><pub-id pub-id-type="doi">10.1073/pnas.87.12.4670</pub-id><pub-id pub-id-type="pmid">2162053</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Bussolino</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>JM</given-names></name><name><surname>Defilippi</surname><given-names>P</given-names></name><name><surname>Turrini</surname><given-names>F</given-names></name><name><surname>Sanavio</surname><given-names>F</given-names></name><name><surname>Edgell</surname><given-names>CJ</given-names></name><name><surname>Aglietta</surname><given-names>M</given-names></name><name><surname>Arese</surname><given-names>P</given-names></name><name><surname>Mantovani</surname><given-names>A</given-names></name><article-title>Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate</article-title><source>Nature</source><year>1989</year><volume>237</volume><fpage>471</fpage><lpage>473</lpage><pub-id pub-id-type="pmid">2464767</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Baldwin</surname><given-names>GC</given-names></name><name><surname>Gasson</surname><given-names>JC</given-names></name><name><surname>Kaufman</surname><given-names>SE</given-names></name><name><surname>Quan</surname><given-names>SG</given-names></name><name><surname>Williams</surname><given-names>RE</given-names></name><name><surname>Avalos</surname><given-names>BR</given-names></name><name><surname>Gazdar</surname><given-names>AF</given-names></name><name><surname>Golde</surname><given-names>DW</given-names></name><name><surname>DiPersio</surname><given-names>JF</given-names></name><article-title>Nonhematopoietic tumor cells express functional GM-CSF receptors</article-title><source>Blood</source><year>1989</year><volume>73</volume><fpage>1033</fpage><lpage>1037</lpage><pub-id pub-id-type="pmid">2537665</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Baldwin</surname><given-names>GC</given-names></name><name><surname>Benveniste</surname><given-names>EN</given-names></name><name><surname>Chung</surname><given-names>GY</given-names></name><name><surname>Gasson</surname><given-names>JC</given-names></name><name><surname>Golde</surname><given-names>DW</given-names></name><article-title>Identification and characterization of a high-affinity granulocyte-macrophage colony-stimulating factor receptor on primary rat oligodendrocytes</article-title><source>Blood</source><year>1993</year><volume>82</volume><fpage>3279</fpage><lpage>3282</lpage><pub-id pub-id-type="pmid">8241500</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Jasper</surname><given-names>MJ</given-names></name><name><surname>Br&#x000e4;nnstr&#x000f6;m</surname><given-names>M</given-names></name><name><surname>Olofsson</surname><given-names>JI</given-names></name><name><surname>Petrucco</surname><given-names>OM</given-names></name><name><surname>Mason</surname><given-names>H</given-names></name><name><surname>Robertson</surname><given-names>SA</given-names></name><name><surname>Norman</surname><given-names>RJ</given-names></name><article-title>Granulocyte-macrophage colony-stimulating factor: presence in human follicular fluid, protein secretion and mRNA expression by ovarian cells</article-title><source>Mol Hum Reprod</source><year>1996</year><volume>8</volume><fpage>555</fpage><lpage>562</lpage><pub-id pub-id-type="pmid">9239667</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Vilanova</surname><given-names>LT</given-names></name><name><surname>Rauch</surname><given-names>MC</given-names></name><name><surname>Mansilla</surname><given-names>A</given-names></name><name><surname>Zambrano</surname><given-names>A</given-names></name><name><surname>Brito</surname><given-names>M</given-names></name><name><surname>Werner</surname><given-names>E</given-names></name><name><surname>Alfaro</surname><given-names>V</given-names></name><name><surname>Cox</surname><given-names>JF</given-names></name><name><surname>Concha</surname><given-names>II</given-names></name><article-title>Expression of granulocyte-macrophage colony stimulating factor (GM-CSF) in male germ cells: GM-CSF enhances sperm motility</article-title><source>Theriogenology</source><year>2003</year><volume>60</volume><fpage>1083</fpage><lpage>1095</lpage><pub-id pub-id-type="doi">10.1016/S0093-691X(03)00106-7</pub-id><pub-id pub-id-type="pmid">12935848</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Chegini</surname><given-names>N</given-names></name><article-title>Human fallopian tube expresses granulocyte-macrophage colony stimulating factor (GM-CSF) and GM-CSF alpha and beta receptors and contains immunoreactive GM-CSF protein</article-title><source>J Clin Endocrinol Metab</source><year>1994</year><volume>79</volume><fpage>662</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1210/jc.79.2.662</pub-id><pub-id pub-id-type="pmid">7519195</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Robertson</surname><given-names>SA</given-names></name><name><surname>Mayrhofer</surname><given-names>G</given-names></name><name><surname>Seamark</surname><given-names>RF</given-names></name><article-title>Ovarian steroid hormones regulate granulocyte-macrophage colony-stimulating factor synthesis by uterine epithelial cells in the mouse</article-title><source>Biol Reprod</source><year>1996</year><volume>54</volume><fpage>183</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1095/biolreprod54.1.183</pub-id><pub-id pub-id-type="pmid">8838016</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Br&#x000e4;nnstr&#x000f6;m</surname><given-names>M</given-names></name><name><surname>Norman</surname><given-names>RJ</given-names></name><name><surname>Seamark</surname><given-names>RF</given-names></name><name><surname>Robertson</surname><given-names>SA</given-names></name><article-title>Rat ovary produces cytokines during ovulation</article-title><source>Biol Reprod</source><year>1994</year><volume>50</volume><fpage>88</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1095/biolreprod50.1.88</pub-id><pub-id pub-id-type="pmid">8312455</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>McGuire</surname><given-names>WJ</given-names></name><name><surname>Imakawa</surname><given-names>K</given-names></name><name><surname>Tamura</surname><given-names>K</given-names></name><name><surname>Meka</surname><given-names>CSR</given-names></name><name><surname>Christenson</surname><given-names>RK</given-names></name><article-title>Regulation of endometrial granulocyte macrophage-colony stimulating factor (GM-CSF) in the ewe</article-title><source>Domest Anim Endocrinol</source><year>2002</year><volume>23</volume><fpage>383</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1016/S0739-7240(02)00181-9</pub-id><pub-id pub-id-type="pmid">12206872</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Sjoblom</surname><given-names>C</given-names></name><name><surname>Wikland</surname><given-names>M</given-names></name><name><surname>Robertson</surname><given-names>SA</given-names></name><article-title>Granulocyte-macrophage colony-stimulating factor (GM-CSF) acts independently of the beta common subunit of the GM-CSF receptor to prevent inner cell mass apoptosis in human embryos</article-title><source>Biol Reprod</source><year>2002</year><volume>67</volume><fpage>1817</fpage><lpage>1823</lpage><pub-id pub-id-type="doi">10.1095/biolreprod.101.001503</pub-id><pub-id pub-id-type="pmid">12444058</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Rong</surname><given-names>H</given-names></name><name><surname>Chegini</surname><given-names>N</given-names></name><article-title>Expression and selective cellular localization of granulocyte-macrophage colony-stimulating factor (GM-CSF) and GM-CSF alpha and beta receptor messenger ribonucleic acid and protein in human ovarian tissue</article-title><source>Biol Reprod</source><year>1995</year><volume>53</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1095/biolreprod53.4.923</pub-id><pub-id pub-id-type="pmid">8547489</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Tamura</surname><given-names>K</given-names></name><name><surname>Tamura</surname><given-names>H</given-names></name><name><surname>Kumasaka</surname><given-names>K</given-names></name><name><surname>Miyajima</surname><given-names>A</given-names></name><name><surname>Suga</surname><given-names>T</given-names></name><name><surname>Kogo</surname><given-names>H</given-names></name><article-title>Ovarian immune cells express granulocyte-macrophage colony-stimulating factor (GM-CSF) during follicular growth and luteinization in gonadotropin-primed immature rodents</article-title><source>Mol Cell Endocrinol</source><year>1998</year><volume>142</volume><fpage>153</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/S0303-7207(98)00109-9</pub-id><pub-id pub-id-type="pmid">9783911</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Gilchrist</surname><given-names>RB</given-names></name><name><surname>Rowe</surname><given-names>DB</given-names></name><name><surname>Ritter</surname><given-names>LJ</given-names></name><name><surname>Robertson</surname><given-names>SA</given-names></name><name><surname>Norman</surname><given-names>RJ</given-names></name><name><surname>Armstrong</surname><given-names>DT</given-names></name><article-title>Effect of granulocyte-macrophage colony-stimulating factor deficiency on ovarian follicular cell function</article-title><source>J Reprod Fertil</source><year>2000</year><volume>120</volume><fpage>283</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">11058444</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Ding</surname><given-names>DX</given-names></name><name><surname>Rivas</surname><given-names>CI</given-names></name><name><surname>Heaney</surname><given-names>ML</given-names></name><name><surname>Raines</surname><given-names>MA</given-names></name><name><surname>Vera</surname><given-names>JC</given-names></name><name><surname>Golde</surname><given-names>DW</given-names></name><article-title>The alpha subunit of the human granulocyte-macrophage colony-stimulating factor receptor signals for glucose transport via a phosphorylation-independent pathway</article-title><source>Proc Natl Acad Sci USA</source><year>1994</year><volume>91</volume><fpage>2537</fpage><lpage>2541</lpage><pub-id pub-id-type="doi">10.1073/pnas.91.7.2537</pub-id><pub-id pub-id-type="pmid">8146150</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Eppig</surname><given-names>J</given-names></name><article-title>Oocyte control of ovarian follicular development and function in mammals</article-title><source>Reproduction</source><year>2001</year><volume>122</volume><fpage>829</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1530/rep.0.1220829</pub-id><pub-id pub-id-type="pmid">11732978</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>McNatty</surname><given-names>KP</given-names></name><name><surname>Reader</surname><given-names>K</given-names></name><name><surname>Smith</surname><given-names>P</given-names></name><name><surname>Heath</surname><given-names>DA</given-names></name><name><surname>Juengel</surname><given-names>JL</given-names></name><article-title>Control of ovarian follicular development to the gonadotrophin-dependent phase: a 2006 perspective</article-title><source>Soc Reprod Fertil Suppl</source><year>2007</year><volume>64</volume><fpage>55</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">17491140</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Dode</surname><given-names>MA</given-names></name><name><surname>Graves</surname><given-names>C</given-names></name><article-title>Involvement of steroid hormones on in vitro maturation of pig oocytes</article-title><source>Theriogenology</source><year>2002</year><volume>57</volume><fpage>811</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1016/S0093-691X(01)00700-2</pub-id><pub-id pub-id-type="pmid">11991385</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Wongsrikeao</surname><given-names>P</given-names></name><name><surname>Kaneshige</surname><given-names>Y</given-names></name><name><surname>Ooki</surname><given-names>R</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Agung</surname><given-names>B</given-names></name><name><surname>Nii</surname><given-names>M</given-names></name><name><surname>Otoi</surname><given-names>T</given-names></name><article-title>Effect of the removal of cumulus cells on the nuclear maturation, fertilization and development of porcine oocytes</article-title><source>Reprod Dom Anim</source><year>2005</year><volume>40</volume><fpage>166</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1111/j.1439-0531.2005.00576.x</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Van Soom</surname><given-names>A</given-names></name><name><surname>Tanghe</surname><given-names>S</given-names></name><name><surname>De Pauw</surname><given-names>I</given-names></name><name><surname>Maes</surname><given-names>D</given-names></name><name><surname>de Kruif</surname><given-names>A</given-names></name><article-title>Functions of the cumulus oophorus before and during mammalian fertilization</article-title><source>Reprod Domest Anim</source><year>2002</year><volume>37</volume><fpage>144</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1046/j.1439-0531.2002.00345.x</pub-id><pub-id pub-id-type="pmid">12071888</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Downs</surname><given-names>SM</given-names></name><article-title>The influence of glucose, cumulus cells, and metabolic coupling on ATP levels and meiotic control in the isolated mouse oocyte</article-title><source>Dev Biol</source><year>1995</year><volume>167</volume><fpage>502</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1006/dbio.1995.1044</pub-id><pub-id pub-id-type="pmid">7875374</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Downs</surname><given-names>SM</given-names></name><name><surname>Utecht</surname><given-names>AM</given-names></name><article-title>Metabolism of radiolabeled glucose by mouse oocytes and oocyte-cumulus cell complexes</article-title><source>Biol Reprod</source><year>1999</year><volume>60</volume><fpage>1446</fpage><lpage>1452</lpage><pub-id pub-id-type="doi">10.1095/biolreprod60.6.1446</pub-id><pub-id pub-id-type="pmid">10330104</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Downs</surname><given-names>S</given-names></name><name><surname>Hudson</surname><given-names>E</given-names></name><article-title>Energy substrates and the completion of spontaneous meiotic maturation</article-title><source>Zygote</source><year>2000</year><volume>8</volume><fpage>339</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1017/S0967199400001131</pub-id><pub-id pub-id-type="pmid">11108555</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Russell</surname><given-names>P</given-names></name><name><surname>Larsen</surname><given-names>W</given-names></name><article-title>Functional significance of cumulus expansion in the mouse: roles for the preovulatory synthesis of hyaluronic acid within the cumulus mass</article-title><source>Mol Reprod Dev</source><year>1993</year><volume>34</volume><fpage>87</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1002/mrd.1080340114</pub-id><pub-id pub-id-type="pmid">8418823</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Constancia</surname><given-names>M</given-names></name><name><surname>Hemberger</surname><given-names>M</given-names></name><name><surname>Highes</surname><given-names>J</given-names></name><name><surname>Dean</surname><given-names>W</given-names></name><name><surname>Ferguson-Smith</surname><given-names>A</given-names></name><name><surname>Fundele</surname><given-names>R</given-names></name><name><surname>Stewart</surname><given-names>F</given-names></name><name><surname>Kelsey</surname><given-names>G</given-names></name><name><surname>Fowden</surname><given-names>A</given-names></name><name><surname>Sibley</surname><given-names>C</given-names></name><name><surname>Reik</surname><given-names>W</given-names></name><article-title>Placental-specific IGF-II is a major modulator of placental and fetal growth</article-title><source>Nature</source><year>2002</year><volume>417</volume><fpage>945</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1038/nature00819</pub-id><pub-id pub-id-type="pmid">12087403</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Harvey</surname><given-names>MB</given-names></name><name><surname>Kaye</surname><given-names>PL</given-names></name><article-title>IGF-2 stimulates growth and metabolism of early mouse embryos</article-title><source>Mech Dev</source><year>1992</year><volume>33</volume><fpage>270</fpage><lpage>275</lpage></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Leibfried</surname><given-names>L</given-names></name><name><surname>First</surname><given-names>NL</given-names></name><article-title>Characterization of bovine follicular oocytes and their ability to mature in vitro</article-title><source>J Anim Sci</source><year>1979</year><volume>48</volume><fpage>76</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">573253</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Downs</surname><given-names>S</given-names></name><article-title>Specificity of epidermal growth factor action on maturation of the murine oocyte and cumulus oophorus in vitro</article-title><source>Biol Reprod</source><year>1989</year><volume>41</volume><fpage>371</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1095/biolreprod41.2.371</pub-id><pub-id pub-id-type="pmid">2508778</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Fagbohun</surname><given-names>C</given-names></name><name><surname>Downs</surname><given-names>S</given-names></name><article-title>Maturation of the mouse oocyte-cumulus cell complex: stimulation by lectins</article-title><source>Biol Reprod</source><year>1990</year><volume>42</volume><fpage>413</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1095/biolreprod42.3.413</pub-id><pub-id pub-id-type="pmid">1692744</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Damiani</surname><given-names>P</given-names></name><name><surname>Fissore</surname><given-names>RA</given-names></name><name><surname>Cibelli</surname><given-names>JB</given-names></name><name><surname>Long</surname><given-names>CR</given-names></name><name><surname>Balise</surname><given-names>JJ</given-names></name><name><surname>Robl</surname><given-names>JM</given-names></name><name><surname>Duby</surname><given-names>RT</given-names></name><article-title>Evaluation of developmental competence, nuclear and ooplasmic maturation of calf oocytes</article-title><source>Mol Reprod Dev</source><year>1996</year><volume>45</volume><fpage>521</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1098-2795(199612)45:4&#x0003c;521::AID-MRD15&#x0003e;3.0.CO;2-Z</pub-id><pub-id pub-id-type="pmid">8956291</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Brackett</surname><given-names>BG</given-names></name><name><surname>Bousquet</surname><given-names>D</given-names></name><name><surname>Boice</surname><given-names>ML</given-names></name><name><surname>Donawick</surname><given-names>WJ</given-names></name><name><surname>Evans</surname><given-names>JF</given-names></name><name><surname>Dressel</surname><given-names>MA</given-names></name><article-title>Normal development following in vitro fertilization in the cow</article-title><source>Biol Reprod</source><year>1982</year><volume>27</volume><fpage>147</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1095/biolreprod27.1.147</pub-id><pub-id pub-id-type="pmid">6896830</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Parrish</surname><given-names>JJ</given-names></name><name><surname>Krogenaes</surname><given-names>A</given-names></name><name><surname>Susko-Parrish</surname><given-names>JL</given-names></name><article-title>Effect of bovine sperm separation by either swim-up or Percoll method on success of <italic>in vitro</italic> fertilization and early embryonic development</article-title><source>Theriogenology</source><year>1995</year><volume>44</volume><fpage>859</fpage><lpage>869</lpage><pub-id pub-id-type="doi">10.1016/0093-691X(95)00271-9</pub-id><pub-id pub-id-type="pmid">16727781</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Gandhi</surname><given-names>AP</given-names></name><name><surname>Lane</surname><given-names>M</given-names></name><name><surname>Gardner</surname><given-names>DK</given-names></name><name><surname>Krisher</surname><given-names>RL</given-names></name><article-title>A single medium supports development of bovine embryos throughout maturation, fertilization and culture</article-title><source>Hum Reprod</source><year>2000</year><volume>15</volume><fpage>395</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1093/humrep/15.2.395</pub-id><pub-id pub-id-type="pmid">10655312</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>Robertson</surname><given-names>SA</given-names></name><name><surname>Roberts</surname><given-names>CT</given-names></name><name><surname>Farr</surname><given-names>KL</given-names></name><name><surname>Dunn</surname><given-names>AR</given-names></name><name><surname>Seamark</surname><given-names>RF</given-names></name><article-title>Fertility impairment in granulocyte-macrophage colony-stimulating factor-deficient mice</article-title><source>Biol Reprod</source><year>1999</year><volume>60</volume><fpage>251</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1095/biolreprod60.2.251</pub-id><pub-id pub-id-type="pmid">9915988</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><name><surname>Zambrano</surname><given-names>A</given-names></name><name><surname>Noli</surname><given-names>C</given-names></name><name><surname>Rauch</surname><given-names>MC</given-names></name><name><surname>Werner</surname><given-names>E</given-names></name><name><surname>Brito</surname><given-names>M</given-names></name><name><surname>Amthauer</surname><given-names>R</given-names></name><name><surname>Slebe</surname><given-names>JC</given-names></name><name><surname>Vera</surname><given-names>JC</given-names></name><name><surname>Concha</surname><given-names>II</given-names></name><article-title>Expression of GM-CSF receptors in male germ cells and their role in signaling for increased glucose and vitamin C transport</article-title><source>J Cell Biochem</source><year>2001</year><volume>80</volume><fpage>625</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1002/1097-4644(20010315)80:4&#x0003c;625::AID-JCB1017&#x0003e;3.0.CO;2-9</pub-id><pub-id pub-id-type="pmid">11169747</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><name><surname>Hercus</surname><given-names>TR</given-names></name><name><surname>Thomas</surname><given-names>D</given-names></name><name><surname>Guthridge</surname><given-names>MA</given-names></name><name><surname>Ekert</surname><given-names>PG</given-names></name><name><surname>King-Scott</surname><given-names>J</given-names></name><name><surname>Parker</surname><given-names>MW</given-names></name><name><surname>Lopez</surname><given-names>AF</given-names></name><article-title>The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease</article-title><source>Blood</source><year>2009</year><volume>114</volume><fpage>1289</fpage><lpage>1298</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-12-164004</pub-id><pub-id pub-id-type="pmid">19436055</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><name><surname>Guthridge</surname><given-names>MA</given-names></name><name><surname>Stomski</surname><given-names>FC</given-names></name><name><surname>Thomas</surname><given-names>D</given-names></name><name><surname>Woodcock</surname><given-names>JM</given-names></name><name><surname>Bagley</surname><given-names>CJ</given-names></name><name><surname>Berndt</surname><given-names>MC</given-names></name><name><surname>Lopez</surname><given-names>AF</given-names></name><article-title>Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors</article-title><source>Stem Cells</source><year>1998</year><volume>16</volume><fpage>301</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1002/stem.160301</pub-id><pub-id pub-id-type="pmid">9766809</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><name><surname>Yaseen</surname><given-names>MA</given-names></name><name><surname>Wrenzycki</surname><given-names>C</given-names></name><name><surname>Herrmann</surname><given-names>D</given-names></name><name><surname>Carnwath</surname><given-names>JW</given-names></name><name><surname>Niemann</surname><given-names>H</given-names></name><article-title>Changes in the relative abundance of mRNA transcripts for insulin-like growth factor (IGF-I and IGF-II) ligands and the receptors (IGF-IR/IGF-IIR) in preimplantation bovine embryos derived from different in vitro systems</article-title><source>Reproduction</source><year>2001</year><volume>122</volume><fpage>601</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1530/rep.0.1220601</pub-id><pub-id pub-id-type="pmid">11570968</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><name><surname>Block</surname><given-names>J</given-names></name><name><surname>Hansen</surname><given-names>PJ</given-names></name><name><surname>Loureiro</surname><given-names>B</given-names></name><name><surname>Bonilla</surname><given-names>L</given-names></name><article-title>Improving post-transfer survival of bovine embryos produced in vitro: actions of insulin-like growth factor-1, colony stimulating factor-2 and hyaluran</article-title><source>Theriogenology</source><year>2011</year><volume>76</volume><fpage>1602</fpage><lpage>1609</lpage><pub-id pub-id-type="doi">10.1016/j.theriogenology.2011.07.025</pub-id><pub-id pub-id-type="pmid">21890189</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><name><surname>Kawamura</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Shu</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Qiao</surname><given-names>J</given-names></name><name><surname>Behr</surname><given-names>B</given-names></name><name><surname>Reijo Pera</surname><given-names>RA</given-names></name><name><surname>Hsueh</surname><given-names>AJW</given-names></name><article-title>Promotion of human early embryonic development and blastocyst outgrowth in vitro using autocrine/paracrine growth factors</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e493</fpage><lpage>e528</lpage></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><name><surname>Loureiro</surname><given-names>B</given-names></name><name><surname>Block</surname><given-names>J</given-names></name><name><surname>Favoreto</surname><given-names>MG</given-names></name><name><surname>Carambula</surname><given-names>S</given-names></name><name><surname>Pennington</surname><given-names>KA</given-names></name><name><surname>Ealy</surname><given-names>AD</given-names></name><name><surname>Hansen</surname><given-names>PJ</given-names></name><article-title>Consequences of conceptus exposure to colony-stimulating factor 2 on survival, elongation, interferon-&#x003c4; secretion, and gene expression</article-title><source>Reproduction</source><year>2011</year><volume>141</volume><fpage>617</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1530/REP-10-0511</pub-id><pub-id pub-id-type="pmid">21339286</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><name><surname>Ziebe</surname><given-names>S</given-names></name><name><surname>Loft</surname><given-names>A</given-names></name><name><surname>Povlsen</surname><given-names>BB</given-names></name><name><surname>Erb</surname><given-names>K</given-names></name><name><surname>Agerholm</surname><given-names>I</given-names></name><name><surname>Aasted</surname><given-names>M</given-names></name><name><surname>Gabrielsen</surname><given-names>A</given-names></name><name><surname>Hnida</surname><given-names>C</given-names></name><name><surname>Zobel</surname><given-names>DP</given-names></name><name><surname>Munding</surname><given-names>B</given-names></name><name><surname>Bendz</surname><given-names>SH</given-names></name><name><surname>Robertson</surname><given-names>SA</given-names></name><article-title>A randomized clinical trial to evaluate the effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) in embryo culture medium for in vitro fertilization</article-title><source>Fertil Steril</source><year>2013</year><volume>99</volume><issue>6</issue><fpage>1600</fpage><lpage>1609</lpage><pub-id pub-id-type="doi">10.1016/j.fertnstert.2012.12.043</pub-id><pub-id pub-id-type="pmid">23380186</pub-id></mixed-citation></ref></ref-list></back></article>